Emerging Technologies in Cell and Gene therapy
Summary
The EIC aims to identify and support breakthrough technologies and game changing innovations to create new markets and scale up internationally and it has been established under the EU Horizon Europe Programme.
Programme Name
Programme Description
Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
Call
Detailed Call Description
Proposers are invited to submit disease-specific or non-disease-specific proposals, focused on emerging technologies or technological solutions aimed to overcome the current cell and gene therapy challenges in one or several the areas listed below, but without being restricted only to these areas:
- Advancing cell therapy manufacturing and products to a clinical stage
- Improving adoptive cell therapies (CAR-T, TCR, TIL)
- Identifying next generation cell therapies for cancer
- Applying cell therapy to treat cancer patients in a personalised manner
- Improving the effectiveness and lowering the risks of gene delivery systems (vectors)
- Improving gene therapy manufacturing processes and production
In order for the proposal to be accepted, it must be focused on emerging technologies or breakthrough new concept-based technological solution that go far beyond the current state-of-the art, aimed to overcome cell and gene therapy challenges and obstacles companies are currently being faced with, at the preclinical or clinical level or bio-manufacturing level.
The gender dimension in research content should be taken into account, where relevant.
Financing percentage by EU or other bodies / Level of Subsidy or Loan
100%
Programme Category
EU Competitive ProgrammesTotal Budget
€132,000,000Thematic Categories
- Education and training
- Health
- Research, Technological Development and Innovation
- Small-Medium Enterprises and Competitiveness
Eligibility for Participation
- Educational Institutions
- National Contact Points - NCPs
- Private Bodies
- Researchers/Research Centers/Institutions
- Small and Medium Enterprises (SMEs)
Call Opening Date
15/06/2021Call Closing Date
27/10/2021National Contact Point(s)
Research and Innovation Foundation
29a Andrea Michalakopoulou, 1075 Nicosia
P.O.Box 23422, 1683 Nicosia
Phone Number: +357 22205000
Email Address: support@research.org.cy
Website: https://www.research.org.cy/en/
Contact Persons:
Ms Katerina Karakasidou
Scientific Officer
Contact Phone: +357 22 205 036
Contact Email: kkarakasidou@research.org.cy
Dr Kalypso Sepou
Head of European Programmes Department
Contact Phone: +357 22 205066
Contact Email: kalypso@research.org.cy
EU Contact Point
European Innovation Council: https://eic.ec.europa.eu/contact-form_en